Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

Savan Shah; Chetasi Talati; Najla Al Ali; Eric Padron; David A. Sallman; Kendra Sweet; Jeffrey E. Lancet; Alan F. List; Kenneth S. Zuckerman; Rami S. Komrokji

doi:10.1182/blood.v130.suppl_1.4186.4186

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

Identifier:nobleid.org/w1/20260515/AA2C1DCD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AA2C1DCD.svg?ark=w1%2F20260515%2FAA2C1DCD)](https://nobleid.org/work/w1/20260515/AA2C1DCD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Between a Rux and a Hard Place: Investigating Causes of Ruxolitinib Discontinuation, Salvage Treatment and Outcome in Myelofibrosis

Identifier:nobleid.org/w1/20260515/AA2C1DCD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AA2C1DCD.svg?ark=w1%2F20260515%2FAA2C1DCD)](https://nobleid.org/work/w1/20260515/AA2C1DCD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work